Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2020, Payable on or Before August 31, 2021
March 26, 2021 at 10:28 am EDT
Share
Shanghai Haohai Biological Technology Co., Ltd. announced that the Board proposed to declare the final dividend of RMB 0.50 per share for the year ended December 31, 2020, amounting to RMB 88,311,050 in total. The above proposal will be put forward at the 2020 annual general meeting of the company for consideration and approval. The specific arrangements regarding the final dividend and its distribution, and the time and arrangement of the closure of register of members of H Shares will be announced separately by the company in a circular of the AGM. If these matters are approved at the AGM, the company expects to distribute the dividend within two months after the date of the AGM (expected to be on or before August 31, 2021). The company shall announce separately the expected dividend payment date.
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.